Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, reposted from Takeda on LinkedIn:
”During International Plasma Awareness Week, we honor the unseen heroes – plasma donors – and the life-changing impact of their generosity.
The Plasma Protein Therapeutics Association has designated “Plasma Powers Possibility” as this year’s theme, which speaks to the courage of patients and the compassion of those who help them.
At BioLife Plasma Services, our employees know that every donation could mean a better tomorrow for someone who relies on medicine made from plasma.
I want to thank all our employees for their commitment to creating a safe, comfortable, and convenient plasma donation experience for our donors every day.”
Takeda shared on LinkedIn:
”International Plasma Awareness Week (IPAW) is here!
This week, we shine a light on the vital importance of plasma donation, and its life-changing impact on individuals living with rare and serious conditions around the world.
For hundreds of thousands of people globally, medicines made from plasma are essential – and often, their only treatment option.
Plasma’s availability depends on the generosity of donors, making every plasma donation a precious gift.
See plasma’s journey from donor to patient below, and join us in championing this life-sustaining resource.”
Stay updated on the emerging with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025